Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results
Go back to Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results| (NASDAQ: CRVS) | Delayed: 12.56 +0.01 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.55 | 52 Week High | $17.77 | |||
| Open | $12.53 | 52 Week Low | $9.63 | |||
| Day High | $12.61 | P/E | N/A | |||
| Day Low | $12.25 | EPS | $0.00 | |||
| Volume | 4,460,675 | |||||

